Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monique Hinchcliff

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Current Opinion in Rheumatology|November 25, 2024
Systemic sclerosis: beyond skin and lung involvementMonique Hinchcliff
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2020
Lenabasum for Skin Disease in Patients With Diffuse Cutaneous Systemic SclerosisMonique Hinchcliff
Nature Reviews. Rheumatology|February 19, 2014
Connective tissue diseases: systemic sclerosis: beyond limited and diffuse subsets?John Varga, Monique Hinchcliff
Current Rheumatology Reports|June 21, 2020
Current and Potential New Targets in Systemic Sclerosis Therapy: a New HopeMonique Hinchcliff, Steven O'Reilly
American Family Physician|October 29, 2008
Systemic sclerosis/scleroderma: a treatable multisystem diseaseMonique Hinchcliff, John Varga
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 29, 2021
FDG PET vascular imaging in IgG4-RD: Potential and challengesDarko Pucar, Monique Hinchcliff
Current Rheumatology Reports|April 18, 2007
Novel paradigm for treating vasculopathy in systemic sclerosis: vascular progenitor cells and statinsMonique Hinchcliff, John Varga
Current Treatment Options in Rheumatology|April 24, 2025
Soluble Biomarkers for Prediction of Vascular and Gastrointestinal Disease Severity in Patients with Systemic SclerosisMiruna Carnaru, Monique Hinchcliff
Expert Review of Clinical Immunology|May 19, 2010
Obliterative vasculopathy in systemic sclerosis: endothelial precursor cells as novel targets for therapyMonique Hinchcliff, John Varga
Clinics in Chest Medicine|August 5, 2019
Connective Tissue Disease-Associated Interstitial Lung Disease: Evaluation and ManagementDanielle Antin-Ozerkis, Monique Hinchcliff
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Current Opinion in Rheumatology|November 25, 2024
Systemic sclerosis: beyond skin and lung involvementMonique Hinchcliff
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2020
Lenabasum for Skin Disease in Patients With Diffuse Cutaneous Systemic SclerosisMonique Hinchcliff
Nature Reviews. Rheumatology|February 19, 2014
Connective tissue diseases: systemic sclerosis: beyond limited and diffuse subsets?John Varga, Monique Hinchcliff
Current Rheumatology Reports|June 21, 2020
Current and Potential New Targets in Systemic Sclerosis Therapy: a New HopeMonique Hinchcliff, Steven O'Reilly
American Family Physician|October 29, 2008
Systemic sclerosis/scleroderma: a treatable multisystem diseaseMonique Hinchcliff, John Varga
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 29, 2021
FDG PET vascular imaging in IgG4-RD: Potential and challengesDarko Pucar, Monique Hinchcliff
Current Rheumatology Reports|April 18, 2007
Novel paradigm for treating vasculopathy in systemic sclerosis: vascular progenitor cells and statinsMonique Hinchcliff, John Varga
Current Treatment Options in Rheumatology|April 24, 2025
Soluble Biomarkers for Prediction of Vascular and Gastrointestinal Disease Severity in Patients with Systemic SclerosisMiruna Carnaru, Monique Hinchcliff
Expert Review of Clinical Immunology|May 19, 2010
Obliterative vasculopathy in systemic sclerosis: endothelial precursor cells as novel targets for therapyMonique Hinchcliff, John Varga
Clinics in Chest Medicine|August 5, 2019
Connective Tissue Disease-Associated Interstitial Lung Disease: Evaluation and ManagementDanielle Antin-Ozerkis, Monique Hinchcliff
Pageof 12